248 related articles for article (PubMed ID: 18451161)
1. Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression.
Anzo M; Cobb LJ; Hwang DL; Mehta H; Said JW; Yakar S; LeRoith D; Cohen P
Cancer Res; 2008 May; 68(9):3342-9. PubMed ID: 18451161
[TBL] [Abstract][Full Text] [Related]
2. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
3. Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model.
Shukla S; MacLennan GT; Fu P; Gupta S
Pharm Res; 2012 Jun; 29(6):1506-17. PubMed ID: 22139534
[TBL] [Abstract][Full Text] [Related]
4. Insulin-Like growth factor 1 related pathways and high-fat diet promotion of transgenic adenocarcinoma mouse prostate (TRAMP) cancer progression.
Xu H; Jiang HW; Ding Q
Actas Urol Esp; 2015 Apr; 39(3):161-8. PubMed ID: 25442907
[TBL] [Abstract][Full Text] [Related]
5. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer.
Adhami VM; Siddiqui IA; Ahmad N; Gupta S; Mukhtar H
Cancer Res; 2004 Dec; 64(23):8715-22. PubMed ID: 15574782
[TBL] [Abstract][Full Text] [Related]
6. The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice.
Takahara K; Ibuki N; Ghaffari M; Tearle H; Ong CJ; Azuma H; Gleave ME; Pollak M; Cox ME
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):239-47. PubMed ID: 23689346
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance.
Haluzik M; Yakar S; Gavrilova O; Setser J; Boisclair Y; LeRoith D
Diabetes; 2003 Oct; 52(10):2483-9. PubMed ID: 14514630
[TBL] [Abstract][Full Text] [Related]
8. Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity.
Yakar S; Liu JL; Fernandez AM; Wu Y; Schally AV; Frystyk J; Chernausek SD; Mejia W; Le Roith D
Diabetes; 2001 May; 50(5):1110-8. PubMed ID: 11334415
[TBL] [Abstract][Full Text] [Related]
9. Levels of insulin-like growth factor I (IGF-I) and IGF binding proteins 2 and 3 in serial postoperative serum samples and risk of prostate cancer recurrence.
Yu H; Nicar MR; Shi R; Berkel HJ; Nam R; Trachtenberg J; Diamandis EP
Urology; 2001 Mar; 57(3):471-5. PubMed ID: 11248622
[TBL] [Abstract][Full Text] [Related]
10. The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model.
Mavropoulos JC; Buschemeyer WC; Tewari AK; Rokhfeld D; Pollak M; Zhao Y; Febbo PG; Cohen P; Hwang D; Devi G; Demark-Wahnefried W; Westman EC; Peterson BL; Pizzo SV; Freedland SJ
Cancer Prev Res (Phila); 2009 Jun; 2(6):557-65. PubMed ID: 19470786
[TBL] [Abstract][Full Text] [Related]
11. A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model.
Majeed N; Blouin MJ; Kaplan-Lefko PJ; Barry-Shaw J; Greenberg NM; Gaudreau P; Bismar TA; Pollak M
Oncogene; 2005 Jul; 24(29):4736-40. PubMed ID: 15870705
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols.
Gupta S; Hastak K; Ahmad N; Lewin JS; Mukhtar H
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10350-5. PubMed ID: 11504910
[TBL] [Abstract][Full Text] [Related]
13. Circulating IGF-1 promotes prostate adenocarcinoma via FOXO3A/BIM signaling in a double-transgenic mouse model.
Wang S; Wang N; Yu B; Cao M; Wang Y; Guo Y; Zhang Y; Zhang P; Yu X; Wang S; Zeng L; Liang B; Li X; Wu Y
Oncogene; 2019 Sep; 38(36):6338-6353. PubMed ID: 31312023
[TBL] [Abstract][Full Text] [Related]
14. Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.
Shariat SF; Lamb DJ; Kattan MW; Nguyen C; Kim J; Beck J; Wheeler TM; Slawin KM
J Clin Oncol; 2002 Feb; 20(3):833-41. PubMed ID: 11821468
[TBL] [Abstract][Full Text] [Related]
15. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
[TBL] [Abstract][Full Text] [Related]
16. Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency.
Liao L; Dearth RK; Zhou S; Britton OL; Lee AV; Xu J
Endocrinology; 2006 Aug; 147(8):3877-88. PubMed ID: 16709615
[TBL] [Abstract][Full Text] [Related]
17. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
Wu Y; Yakar S; Zhao L; Hennighausen L; LeRoith D
Cancer Res; 2002 Feb; 62(4):1030-5. PubMed ID: 11861378
[TBL] [Abstract][Full Text] [Related]
18. Interactions of insulin-like growth factor (IGF)-II and growth hormone in vivo: circulating levels of IGF-I and IGF-binding proteins in transgenic mice.
Blackburn A; Dressendörfer RA; Blum WF; Erhard M; Brem G; Strasburger CJ; Wolf E
Eur J Endocrinol; 1997 Dec; 137(6):701-8. PubMed ID: 9437240
[TBL] [Abstract][Full Text] [Related]
19. Deletion of p21/Cdkn1a confers protective effect against prostate tumorigenesis in transgenic adenocarcinoma of the mouse prostate model.
Jain AK; Raina K; Agarwal R
Cell Cycle; 2013 May; 12(10):1598-604. PubMed ID: 23624841
[TBL] [Abstract][Full Text] [Related]
20. A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model.
Tepaamorndech S; Huang L; Kirschke CP
Cancer Lett; 2011 Sep; 308(1):33-42. PubMed ID: 21621325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
